ROLE OF INDIVIDUALISED HOMOEOPATHIC MEDICINES IN THE TREATMENT OF CHRONIC URTICARIA IN ADULTS: A SINGLE ARM PRE-POST ASSESSMENT INTERVENTIONAL STUDY
试验速览
- 阶段
- 3 期
- 状态
- 尚未招募
- 发起方
- 入组人数
- 38
- 试验地点
- 1
研究概览
简要总结
Step 1: Screening of the patients.
Step 2: Selection of the patients clinically diagnosed with chronic urticaria considering the inclusion criteria.
Step 3: Detailed case taking of every patient according as per homoeopathic technique. Patient’s information recorded in standard case taking proforma used in National Institute of Homoeopathy, Delhi.
Step 4: Relevant investigation procedure will be done as per need of the case and inclusion and exclusion criteria will be fulfilled.
Outcome will be measured at definite interval. Scoring for urticaria using UAS7 and UCT scale will be done at baseline and end of third month and MONARCH scoring will be done at the end of the third month.
Step 5: Repertorization will be done using software Hompath 11.
Step 6: Final selection of medicine will be done in consultation with Materia medica. Step7: Potency, dose, and repetition of medicine will be decided according to homoeopathic principle.
Step8: General management such as appropriate diet, regimen and proper lifestyle modification will be advised to each and every patient.
Step 9: Monthly follow up will be done for at least 3 months. And outcome will be assessed at the end of three months.
Step 10: Observing the response of patient through scoring for urticaria using UAS7 scale and UCT.
Step 11: Data comparison Step 12: Data analysis Step 13: Inference
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 盲法
- None
入排标准
- 年龄范围
- 18.00 Year(s) 至 65.00 Year(s)（—）
- 性别
- All
入选标准
- •1.Participants having a clinical diagnosis of chronic urticaria [23], characterized by hives or wheals lasting for more than 6 weeks.
- •2.Age between 18-65 years.[2] 3.Patient’s taking antihistamines will be enrolled after one month of wash out period.
- •4.Participants of all gender, religion and socioeconomic status.
- •5.Participants giving written informed consent to participate in the study.
排除标准
- •1.Patients with other severe dermatological conditions, autoimmune diseases or significant co-morbidities.
- •2.Pregnant or lactating women.
- •3.Patients already undergoing homoeopathic treatment for any chronic disease for last 6 months.
- •4.Patients having any other uncontrolled systemic diseases and on allopathic medications and immunocompromised patients 5.Patients having any psychiatric illness.
- •6.Patients having any addictions and substance abuses.
- •7.Simultaneous participation in any other clinical trial.
研究者
Renu R
National Institute Of Homoeopathy